Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Harman

Showing results (91-100 of 146) with videos related to

Pageof 15
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|October 4, 2022
Evolution avoids a pathological stabilizing interaction in the immune protein S100A9Joseph L Harman, Patrick N Reardon, Shawn M Costello, et al.
Trials|August 9, 2018
Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 Diabetes (SCORE-IT): study protocol for the development of a core outcome setNicola L Harman, John Wilding, Dave Curry, et al.
Nature Communications|December 19, 2018
Publisher Correction: Disease-relevant transcriptional signatures identified in individual smooth muscle cells from healthy mouse vesselsLina Dobnikar, Annabel L Taylor, Joel Chappell, et al.
Nature Communications|November 3, 2018
Disease-relevant transcriptional signatures identified in individual smooth muscle cells from healthy mouse vesselsLina Dobnikar, Annabel L Taylor, Joel Chappell, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|January 11, 2013
Standardized mapping of nursing assessments across 59 U.S. military treatment facilitiesTiffany L Harman, Rachael A Seeley, Ivete M Oliveira, et al.
BMJ Open Diabetes Research & Care|January 8, 2020
Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 diabetes (SCORE-IT): a patient and healthcare professional consensus on a core outcome set for type 2 diabetesNicola L Harman, John P H Wilding, Dave Curry, et al.
Trials|November 11, 2019
Designing and using incentives to support recruitment and retention in clinical trials: a scoping review and a checklist for designBeth Parkinson, Rachel Meacock, Matt Sutton, et al.
Metabolic Syndrome and Related Disorders|August 19, 2010
The triglyceride/high-density lipoprotein cholesterol ratio fails to predict insulin resistance in African-American women: an analysis of Jackson Heart StudyAnne E Sumner, Jane L Harman, Sarah G Buxbaum, et al.
Journal of Clinical Lipidology|May 24, 2011
Age is positively associated with high-density lipoprotein cholesterol among African Americans in cross-sectional analysis: the Jackson Heart StudyJane L Harman, Michael E Griswold, Neal O Jeffries, et al.
The Lancet. Respiratory Medicine|November 5, 2023
Core outcome measurement instruments for use in clinical and research settings for adults with post-COVID-19 condition: an international Delphi consensus studySarah L Gorst, Nina Seylanova, Susanna R Dodd, et al.
Pageof 15

Showing results (91-100 of 146) with videos related to

Sort By:
Pageof 15
Proceedings of the National Academy of Sciences of the United States of America|October 4, 2022
Evolution avoids a pathological stabilizing interaction in the immune protein S100A9Joseph L Harman, Patrick N Reardon, Shawn M Costello, et al.
Trials|August 9, 2018
Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 Diabetes (SCORE-IT): study protocol for the development of a core outcome setNicola L Harman, John Wilding, Dave Curry, et al.
Nature Communications|December 19, 2018
Publisher Correction: Disease-relevant transcriptional signatures identified in individual smooth muscle cells from healthy mouse vesselsLina Dobnikar, Annabel L Taylor, Joel Chappell, et al.
Nature Communications|November 3, 2018
Disease-relevant transcriptional signatures identified in individual smooth muscle cells from healthy mouse vesselsLina Dobnikar, Annabel L Taylor, Joel Chappell, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|January 11, 2013
Standardized mapping of nursing assessments across 59 U.S. military treatment facilitiesTiffany L Harman, Rachael A Seeley, Ivete M Oliveira, et al.
BMJ Open Diabetes Research & Care|January 8, 2020
Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 diabetes (SCORE-IT): a patient and healthcare professional consensus on a core outcome set for type 2 diabetesNicola L Harman, John P H Wilding, Dave Curry, et al.
Trials|November 11, 2019
Designing and using incentives to support recruitment and retention in clinical trials: a scoping review and a checklist for designBeth Parkinson, Rachel Meacock, Matt Sutton, et al.
Metabolic Syndrome and Related Disorders|August 19, 2010
The triglyceride/high-density lipoprotein cholesterol ratio fails to predict insulin resistance in African-American women: an analysis of Jackson Heart StudyAnne E Sumner, Jane L Harman, Sarah G Buxbaum, et al.
Journal of Clinical Lipidology|May 24, 2011
Age is positively associated with high-density lipoprotein cholesterol among African Americans in cross-sectional analysis: the Jackson Heart StudyJane L Harman, Michael E Griswold, Neal O Jeffries, et al.
The Lancet. Respiratory Medicine|November 5, 2023
Core outcome measurement instruments for use in clinical and research settings for adults with post-COVID-19 condition: an international Delphi consensus studySarah L Gorst, Nina Seylanova, Susanna R Dodd, et al.
Pageof 15